AbCellera Biologics (ABCL) Change in Cash (2020 - 2026)
AbCellera Biologics (ABCL) posted Change in Cash of -$51.4 million for Q1 2026, down 214.84% on a QoQ basis from $44.8 million in Q4 2025, and down 1849.4% year-over-year from $2.9 million in Q1 2025.
AbCellera Biologics (ABCL) Change in Cash (2020 - 2026) Analysis & Trends
AbCellera Biologics' Change in Cash history runs 7 years deep, the most recent figure standing at -$51.4 million for Q1 2026.
- Quarterly Change in Cash fell 1849.4% year-over-year to -$51.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$82.8 million (down 331.85% YoY) and the FY2025 annual result came in at -$28.4 million, down 223.3% from the prior year.
- Change in Cash was -$51.4 million for Q1 2026 at AbCellera Biologics, down from $44.8 million in the prior quarter.
- Across five years, Change in Cash topped out at $245.8 million in Q2 2022 and bottomed at -$417.4 million in Q3 2022.
- A 5-year average of -$23.4 million and a median of -$9.3 million in 2025 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2024 — Change in Cash surged 286.42% — and 2026, when it tumbled 1849.4%.
- AbCellera Biologics' Change in Cash stood at $14.6 million in 2022, then sank by 368.51% to -$39.1 million in 2023, then jumped by 175.92% to $29.7 million in 2024, then surged by 50.92% to $44.8 million in 2025, then sank by 214.84% to -$51.4 million in 2026.
- Business Quant data shows ABCL's Change in Cash at -$51.4 million in Q1 2026, $44.8 million in Q4 2025, and -$9.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | AbCellera Biologics | 1.72 Bn | 1.72 Bn | - | -51.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.45 Mn |
| Dec 31, 2025 | 44.80 Mn |
| Sep 30, 2025 | -9.28 Mn |
| Jun 30, 2025 | -66.83 Mn |
| Mar 31, 2025 | 2.94 Mn |
| Dec 31, 2024 | 29.69 Mn |
| Sep 30, 2024 | -21.67 Mn |
| Jun 30, 2024 | 24.74 Mn |
| Mar 31, 2024 | -9.75 Mn |
| Dec 31, 2023 | -39.10 Mn |
| Sep 30, 2023 | -7.33 Mn |
| Jun 30, 2023 | -13.27 Mn |
| Mar 31, 2023 | -194.34 Mn |
| Dec 31, 2022 | 14.56 Mn |
| Sep 30, 2022 | -417.35 Mn |
| Jun 30, 2022 | 245.78 Mn |
| Mar 31, 2022 | 70.51 Mn |
| Dec 31, 2021 | -16.55 Mn |
| Sep 30, 2021 | -274.88 Mn |
| Jun 30, 2021 | 106.78 Mn |